patients undergoing coronary artery bypass grafting. Atherosclerosis of coronary artery bypass graft(s), unspecified, with unspecified angina pectoris
Conditions
Interventions
Intervention 1: Intervention group: Ten grams of whey protein isolate (once a day) for a period of 14 days will be consumed orally after dissolving in water. Intervention 2: Control group: Three grams
Sponsors
Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
30 Years to 75 Years
Inclusion criteria
Inclusion criteria: patients who are undergoing coronary artery bypass grafting age 30-75 years
Exclusion criteria
Exclusion criteria: heart surgery for the second time simultaneous surgeries (such as heart valve surgery) ejection fraction lower than 30 patients with renal failure patients with liver cirrhosis patients with cancer having metabolic amino acid disorders (such as phenylketonuria) patients with malabsorptive syndrome having celiac disease allergy to milk and dairy products patients with Alzheimer's disease patients with active infection pregnant women lactating women receiving levodopa or albendazole medications
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Fasting blood glucose. Timepoint: Before the start of intervention and 14 days after it. Method of measurement: colorimetric method.;Serum triglyceride. Timepoint: Before the start of intervention and 14 days after it. Method of measurement: colorimetric method.;Serum total cholesterol. Timepoint: Before the start of intervention and 14 days after it. Method of measurement: colorimetric method.;Low-density lipoprotein cholesterol (LDL-C). Timepoint: Before the start of intervention and 14 days after it. Method of measurement: colorimetric method.;High-density lipoprotein cholesterol (HDL-C). Timepoint: Before the start of intervention and 14 days after it. Method of measurement: colorimetric method.;Serum albumin. Timepoint: Before the start of intervention and 14 days after it. Method of measurement: colorimetric method.;Quality of life determined by MacNew questionnaire. Timepoint: Before the start of intervention and 14 days after it. Method of measurement: MacNew Heart Disease health-related quality of life questionnaire. | — |
Secondary
| Measure | Time frame |
|---|---|
| Atherogenic Index of plasma. Timepoint: Before the start of intervention and 14 days after it. Method of measurement: logarithm of triglyceride (mmol/l) to high-density lipoprotein cholesterol (mmol/l) ratio.;Total cholesterol to high-density lipoprotein cholesterol (HDL-C) ratio. Timepoint: Before the start of intervention and 14 days after it. Method of measurement: total cholesterol divided by high-density lipoprotein cholesterol.;Low-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (LDL-C/HDL-C). Timepoint: Before the start of intervention and 14 days after it. Method of measurement: low-density lipoprotein cholesterol divided by high-density lipoprotein cholesterol.;Non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio (non-HDL-C/HDL-C). Timepoint: Before the start of intervention and 14 days after it. Method of measurement: First of all, high-density lipoprotein cholesterol (HDL-C) is subtracted from total cholesterol to determine non-high-density lipoprotein cholesterol (non-HDL-C). Then, non-HDL-C is divided by HDL-C. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactMaryam Mohammad-Hosseini
Shiraz University of Medical Sciences
Outcome results
None listed